Heritas Capital

Tessa Therapeutics Pte Ltd. is a biotechnology company focused on developing innovative cancer immunotherapies, specifically targeting solid tumors. Founded in 2011 and based in Singapore, the company specializes in creating virus-specific T cells and CAR T cells aimed at treating lymphoma. By advancing these therapies, Tessa Therapeutics seeks to provide healthcare providers with effective options to improve the lives of cancer patients.

HealthBeats is a company focused on enhancing healthcare through regular remote patient monitoring. Their platform provides a user-friendly solution for health providers and patients, allowing individuals to self-administer medical devices at home from various brands. This technology enables the real-time transmission of health data to healthcare providers, facilitating proactive care management. By promoting consistent monitoring outside traditional healthcare settings, HealthBeats aims to improve patient outcomes and reduce healthcare costs, empowering patients to take an active role in managing their health and well-being.

Holmusk Pte. Ltd. is a digital health and data analytics company focused on delivering real-world evidence for mental health and chronic diseases. Founded in 2015 and headquartered in Singapore, with additional offices in New York, Durham, London, and Cyberjaya, Holmusk develops an analytics platform that integrates scientific research, electronic health records, and behavioral health data to provide predictive algorithms and actionable insights for personalized medicine. The company offers solutions such as MindLinc, an electronic health record system that enhances longitudinal data for advanced analytics, and digital therapeutics that monitor and treat patients. Holmusk's platform supports various stakeholders in the healthcare ecosystem, including pharmaceutical companies, healthcare providers, payers, and regulators, facilitating informed care decisions and improving treatment outcomes for individuals managing behavioral health conditions. Through its innovative approach, Holmusk aims to advance data-driven, evidence-based care and aid in the research and development of new therapies.

ConveGenius is focused on nurturing and harnessing value by providing affordable educational solutions to create impact in large volumes. Their core competence lies in building mobile products/ apps/ games catered for global and local markets likewise. The company is focussed towards providing quality education to children at risk by integrating technology with education and working with state governments to penetrate the rural and semi urban areas of India. It also aims to cater to the global urban market using retailing and e-tailing channels for its various world-class high-end educational solutions. ConveGenius is based out of India and Singapore. Their India office is headquartered in Noida.

Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.

Alchemy Foodtech is a food science and technology company that develops novel active food ingredients that fights diabetes. The company believes the ideal healthcare system to diabetes is one that doesn't let you get it in the first place. By combining disruptive food, bio and medical technologies into everyday food, Alchemy Foodtech provides diabetics with far better disease management and also the general public with diabetes prevention.

SilverConnect is a medical nutrition startup creating specialized food solutions for people with dysphagia. Dysphagia, or the difficulty to swallow, is more common in older people and often results from nerve or muscle problems.

Holmusk Pte. Ltd. is a digital health and data analytics company focused on delivering real-world evidence for mental health and chronic diseases. Founded in 2015 and headquartered in Singapore, with additional offices in New York, Durham, London, and Cyberjaya, Holmusk develops an analytics platform that integrates scientific research, electronic health records, and behavioral health data to provide predictive algorithms and actionable insights for personalized medicine. The company offers solutions such as MindLinc, an electronic health record system that enhances longitudinal data for advanced analytics, and digital therapeutics that monitor and treat patients. Holmusk's platform supports various stakeholders in the healthcare ecosystem, including pharmaceutical companies, healthcare providers, payers, and regulators, facilitating informed care decisions and improving treatment outcomes for individuals managing behavioral health conditions. Through its innovative approach, Holmusk aims to advance data-driven, evidence-based care and aid in the research and development of new therapies.

Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.

Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.

Alchemy Foodtech is a food science and technology company that develops novel active food ingredients that fights diabetes. The company believes the ideal healthcare system to diabetes is one that doesn't let you get it in the first place. By combining disruptive food, bio and medical technologies into everyday food, Alchemy Foodtech provides diabetics with far better disease management and also the general public with diabetes prevention.

Alchemy Foodtech is a food science and technology company that develops novel active food ingredients that fights diabetes. The company believes the ideal healthcare system to diabetes is one that doesn't let you get it in the first place. By combining disruptive food, bio and medical technologies into everyday food, Alchemy Foodtech provides diabetics with far better disease management and also the general public with diabetes prevention.

Holmusk Pte. Ltd. is a digital health and data analytics company focused on delivering real-world evidence for mental health and chronic diseases. Founded in 2015 and headquartered in Singapore, with additional offices in New York, Durham, London, and Cyberjaya, Holmusk develops an analytics platform that integrates scientific research, electronic health records, and behavioral health data to provide predictive algorithms and actionable insights for personalized medicine. The company offers solutions such as MindLinc, an electronic health record system that enhances longitudinal data for advanced analytics, and digital therapeutics that monitor and treat patients. Holmusk's platform supports various stakeholders in the healthcare ecosystem, including pharmaceutical companies, healthcare providers, payers, and regulators, facilitating informed care decisions and improving treatment outcomes for individuals managing behavioral health conditions. Through its innovative approach, Holmusk aims to advance data-driven, evidence-based care and aid in the research and development of new therapies.